RPTOR and ovarian cancer: Pharmacologic inhibition of both kinases by treatment of ovarian cancer cells with THZ531 caused the up-regulation of a proximal ALE event in intron 10 of RAPTOR, leading to the downregulation of more distal exons and repression of RAPTOR protein expression [59].